| Fil Barrozo, MD | |
|
115 W E St, Tehachapi, CA 93561-1607 | |
| (661) 822-3241 | |
| Not Available |
| Full Name | Fil Barrozo |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 115 W E St, Tehachapi, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568406312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MTL-2018-002 (Guam) | Secondary |
| 207P00000X | Emergency Medicine | A38588 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.
Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.
› Verified 6 days ago
| Entity Name | San Dimas Emergency Medical Associates Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720239460 PECOS PAC ID: 0648334235 Enrollment ID: O20090127000007 |
News Archive
MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.
Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.
› Verified 6 days ago
| Entity Name | Orange County Urgent Care #3, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497001200 PECOS PAC ID: 2062667306 Enrollment ID: O20130312000517 |
News Archive
MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.
Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.
› Verified 6 days ago
| Entity Name | Sunshine Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649725466 PECOS PAC ID: 3072893460 Enrollment ID: O20161130001458 |
News Archive
MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.
Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fil Barrozo, MD 28701 Gleneagle Ct, Tehachapi, CA 93561-5223 Ph: () - | Fil Barrozo, MD 115 W E St, Tehachapi, CA 93561-1607 Ph: (661) 822-3241 |
News Archive
MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.
Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.
UCLA neuroscientists using a new MRI analysis technique to examine myelin sheaths that insulate the brain's wiring report that as people age, neural connections that develop last degenerate first.
Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.
› Verified 6 days ago
Roy C. Peterson, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 West E Street, Tehachapi, CA 93581 Phone: 661-972-2874 Fax: 661-823-8106 | |
Dr. Bart Sullivan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 115 W E St, Tehachapi, CA 93561 Phone: 661-822-3241 | |
Vijay K Mohan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 W E St, Tehachapi, CA 93561 Phone: 800-444-7009 | |
Manuel Garrido, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 115 W E St, Tehachapi, CA 93561 Phone: 661-822-3241 |